Clinical Trial Update: Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial [Phase 2]

View source ↗

Summary

Phase 2 pilot feasibility clinical trial at the University of British Columbia evaluating whether psychomotor response to a levodopa (L-DOPA) challenge can serv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• levodopa (levodopa)

Snippet

Sponsor: University of British Columbia | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING